This topic contains a solution. Click here to go to the answer

Author Question: A false positive in screening tests is the event that the test is negative for a given condition, ... (Read 91 times)

erika

  • Hero Member
  • *****
  • Posts: 522
A false positive in screening tests is the event that the test is negative for a given condition, given that the person has the condition.
  Indicate whether the statement is true or false

Question 2

Which of the following statements is false?
 a. A contingency table is an arrangement of data in a two-way classification. The data are sorted into cells, and the number of data in each cell is reported.
  b. In the case of contingency tables, the number of degrees of freedom is exactly the same as the larger of the number of columns or rows in the table.
  c. In general, the r x c contingency table (r is the number of rows; c is the number of columns) is used to test the independence of the row factor and the column factor.
  d. None of the above.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tanna.moeller

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

F

Answer to Question 2

B





 

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

For a complete list of videos, visit our video library